We are live on ! Find out more
ML

McAdam LLC Portfolio holdings

AUM $2.22B
1-Year Est. Return 16.98%
This Fund
S&P 500
This Quarter Est. Return
+1.6%
1 Year Est. Return
+16.98%
3 Year Est. Return
+46.26%
5 Year Est. Return
+42.13%
10 Year Est. Return
AUM
$246M
AUM Growth
+$27.9M
Cap. Flow
+$24.9M
Cap. Flow %
10.14%
Top 10 Hldgs %
64.81%
Holding
904
New
61
Increased
149
Reduced
132
Closed
202

Sector Composition

1 Technology 1.2%
2 Healthcare 1.18%
3 Consumer Discretionary 0.7%
4 Communication Services 0.61%
5 Industrials 0.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHI icon
676
D.R. Horton
DHI
$42.3B
-65
Closed -$3K
DINO icon
677
HF Sinclair
DINO
$15.9B
-27
Closed -$1K
DK icon
678
Delek US
DK
$3.89B
-50
Closed -$2K
DLTR icon
679
Dollar Tree
DLTR
$24.3B
-24
Closed -$2K
DRI icon
680
Darden Restaurants
DRI
$22.7B
-350
Closed -$30K
DXJ icon
681
WisdomTree Japan Hedged Equity Fund
DXJ
$7.04B
-916
Closed -$51K
EBAY icon
682
eBay
EBAY
$49.7B
-75
Closed -$3K
ECL icon
683
Ecolab
ECL
$76.7B
$0 ﹤0.01%
2
-3
-60% -$433
EFX icon
684
Equifax
EFX
$21B
-15
Closed -$2K
EGP icon
685
EastGroup Properties
EGP
$11.9B
-6
Closed
EIRL icon
686
iShares MSCI Ireland ETF
EIRL
$74.6M
$0 ﹤0.01%
1
EMN icon
687
Eastman Chemical
EMN
$7.82B
-83
Closed -$9K
ENR icon
688
Energizer
ENR
$1.39B
-8
Closed
ENTG icon
689
Entegris
ENTG
$20.8B
-36
Closed -$1K
ENVA icon
690
Enova International
ENVA
$5.8B
-19
Closed
EVOK
691
DELISTED
Evoke Pharma
EVOK
0
EW icon
692
Edwards Lifesciences
EW
$49.5B
-78
Closed -$4K
EWBC icon
693
East-West Bancorp
EWBC
$18.3B
-23
Closed -$1K
EWY icon
694
iShares MSCI South Korea ETF
EWY
$19.5B
$0 ﹤0.01%
+2
New +$146
FAF icon
695
First American
FAF
$7.43B
-28
Closed -$2K
FLIC
696
DELISTED
First of Long Island Corp
FLIC
-10
Closed
FR icon
697
First Industrial Realty Trust
FR
$9.11B
-74
Closed -$2K
FRME icon
698
First Merchants
FRME
$2.79B
-62
Closed -$3K
FTS icon
699
Fortis
FTS
$29.9B
-15
Closed -$1K
FUL icon
700
H.B. Fuller
FUL
$3.06B
-29
Closed -$1K

Similar funds

McAdam LLC's Q2 2018 Portfolio in Review

As of Q2 2018, McAdam LLC held 904 positions worth $246M, up 13% from $218M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

McAdam LLC deployed $24.9M of net new capital in Q2 2018, opening 61 new positions and adding to 149 existing holdings. Its largest new stake was BrightSpire Capital: 7,203 shares worth $149K.

By sector, the portfolio is most concentrated in Technology at 1.2% of assets, down from 1.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $131K trimmed.

  • McAdam LLC's largest Q2 2018 buy was BrightSpire Capital: 7,203 shares worth $149K.
  • McAdam LLC added most to Schwab Fundamental US Large Company Index ETF in Q2 2018, an estimated $2.75M increase.
  • McAdam LLC's biggest Q2 2018 reduction was Vertex Pharmaceuticals, cutting an estimated $131K.
  • McAdam LLC fully exited ProShares Short S&P500 in Q2 2018, selling an estimated $76K.
  • McAdam LLC's ten largest holdings make up 65% of its $246M portfolio in Q2 2018.
  • McAdam LLC opened 61 new positions and closed 202 in Q2 2018.
  • McAdam LLC's portfolio value rose 13% quarter-over-quarter to $246M.

Based on McAdam LLC's 13F filing for Q2 2018, filed 22 Aug 2018.